Published in AIDS Care on July 01, 2005
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet (2010) 3.90
Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis (2011) 2.55
Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 1.80
Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective. J Gen Intern Med (2006) 1.41
Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS Behav (2013) 1.35
Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis (2011) 1.29
Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India. AIDS Care (2013) 1.21
Short-term discontinuation of HAART regimens more common in vulnerable patient populations. AIDS Res Hum Retroviruses (2008) 1.15
Challenges in managing HIV in people who use drugs. Curr Opin Infect Dis (2015) 1.13
Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors. AIDS Patient Care STDS (2010) 1.12
The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis. Am J Public Health (2015) 1.11
A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies. PLoS One (2012) 1.09
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis (2013) 1.07
Factors associated with employment among a cohort of injection drug users. Drug Alcohol Rev (2010) 1.06
Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS Behav (2014) 1.02
Offer of financial incentives for unprotected sex in the context of sex work. Drug Alcohol Rev (2010) 1.01
Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems. AIDS Care (2007) 0.97
Linkage to care for HIV-infected heterosexual men in the United States. Clin Infect Dis (2011) 0.95
Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States. J Acquir Immune Defic Syndr (2014) 0.95
High rates of police detention among recently released HIV-infected prisoners in Ukraine: implications for health outcomes. Drug Alcohol Depend (2013) 0.95
Social patterning of screening uptake and the impact of facilitating informed choices: psychological and ethical analyses. Health Care Anal (2007) 0.90
Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDS. PLoS One (2013) 0.87
Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention. Curr HIV/AIDS Rep (2014) 0.87
Structural Barriers to Antiretroviral Therapy Among Sex Workers Living with HIV: Findings of a Longitudinal Study in Vancouver, Canada. AIDS Behav (2016) 0.86
Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting. AIDS Behav (2013) 0.84
Retention in care within 1 year of initial HIV care visit in a multisite US cohort: who's in and who's out? J Int Assoc Provid AIDS Care (2014) 0.84
The HIV Medication Taking Self-efficacy Scale: psychometric evaluation. J Adv Nurs (2010) 0.84
Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users. Vaccine (2009) 0.84
Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada. HIV Med (2014) 0.83
Correlates of unstructured antiretroviral treatment interruption in a cohort of HIV-positive individuals in British Columbia. AIDS Behav (2014) 0.83
The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse (2011) 0.82
Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health (2012) 0.82
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders. Ther Drug Monit (2011) 0.81
Methadone use among HIV-positive injection drug users in a Canadian setting. J Subst Abuse Treat (2010) 0.80
Drug dealing cessation among a cohort of drug users in Vancouver, Canada. Drug Alcohol Depend (2011) 0.80
Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study. AIDS Res Ther (2016) 0.80
Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative. AIDS Behav (2016) 0.79
Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users. Psychol Health Med (2012) 0.78
High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting. AIDS Behav (2015) 0.77
Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs. Epidemiol Infect (2016) 0.75
Bringing health care advocacy to a public defender's office. Am J Public Health (2008) 0.75
Barriers to Viral Suppression Among Female Sex Workers: Role of Structural and Intimate Partner Dynamics. J Acquir Immune Defic Syndr (2016) 0.75
Multiple gaps in care common among newly diagnosed HIV patients. AIDS Care (2015) 0.75
Community mapping of sex work criminalization and violence: impacts on HIV treatment interruptions among marginalized women living with HIV in Vancouver, Canada. Int J STD AIDS (2017) 0.75
Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol (1997) 15.19
A telomerase component is defective in the human disease dyskeratosis congenita. Nature (1999) 7.91
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA (2001) 7.63
Barriers to use of free antiretroviral therapy in injection drug users. JAMA (1998) 6.67
Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature (1995) 5.91
Early haemo-diafiltration in meningococcal septicaemia. Lancet (1996) 5.35
Relation of family responsibilities and gender to the productivity and career satisfaction of medical faculty. Ann Intern Med (1998) 4.52
The hippocampus, memory, and place cells: is it spatial memory or a memory space? Neuron (1999) 4.36
A type VII myosin encoded by the mouse deafness gene shaker-1. Nature (1995) 3.71
Prevention of thrombosis after pelvic surgery by British dextran 70. Lancet (1972) 3.28
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial. JAMA (2001) 3.28
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23
Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet (1997) 2.88
The cost of obesity in Canada. CMAJ (1999) 2.71
CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology (2008) 2.43
Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet (1997) 2.40
Community leg ulcer clinics: a comparative study in two health authorities. BMJ (1996) 2.40
Life expectancy after spinal cord injury: a 50-year study. Spinal Cord (2012) 2.35
Safe injection facilities in Canada: is it time? CMAJ (2001) 2.31
Making Cairo work. Lancet (1999) 2.28
Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development (1998) 2.23
Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res (1995) 2.21
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05
The relationship between HAART use and sexual activity among HIV-positive women of reproductive age in Brazil, South Africa, and Uganda. AIDS Care (2008) 2.03
Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med (1994) 2.01
High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health (Oxf) (2004) 1.95
DNA chips: an array of possibilities. Nat Biotechnol (1998) 1.95
Faculty perceptions of gender discrimination and sexual harassment in academic medicine. Ann Intern Med (2000) 1.93
Science, sex and semantics: the firing of George Lundberg. CMAJ (1999) 1.89
Technological Innovation: New Study Sponsored by NSF Takes Socioeconomic, Managerial Factors into Account. Science (1973) 1.87
Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis (1994) 1.85
Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting. AIDS (1999) 1.85
Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy (2010) 1.75
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med (2006) 1.73
Causes of death after spinal cord injury. Spinal Cord (2000) 1.73
The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART. AIDS (2005) 1.72
Representation for all? Br Dent J (1989) 1.72
Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis. HIV Med (2008) 1.72
Emotional and behavioral impact of exposure to community violence in inner-city adolescents. J Clin Child Psychol (2001) 1.71
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Pharmaceutical industry-sponsored meetings: good value or just a free meal? Intern Med J (2001) 1.69
How effective is syndromic management of STDs?: A review of current studies. Sex Transm Dis (2000) 1.69
Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med (2010) 1.68
Incidence of acquired demyelination of the CNS in Canadian children. Neurology (2009) 1.63
Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol (1993) 1.61
Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res (1995) 1.60
Lidocaine adrenaline tetracaine gel versus tetracaine adrenaline cocaine gel for topical anesthesia in linear scalp and facial lacerations in children aged 5 to 17 years. Pediatrics (1995) 1.60
Molecular signatures of brain injury after intracerebral hemorrhage. Neurology (2002) 1.53
Leg ulcer care: an audit of cost-effectiveness. Health Trends (1996) 1.51
Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke (2001) 1.49
The isolation of non-excluding mutants of phage P22. J Gen Virol (1967) 1.48
Specimen-orientated radiography helps define excision margins of malignant lesions detected by breast screening. Br J Surg (1993) 1.48
High-pressure liquid chromatographic determination of ranitidine, a new H2-receptor antagonist, in plasma and urine. J Pharm Sci (1980) 1.46
Evaluation of red blood cell transfusion practices with the use of preset criteria. CMAJ (1994) 1.46
Hypertrichosis due to minoxidil. Br J Dermatol (1979) 1.45
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med (2010) 1.45
Assessment of in vitro thyroid function tests in 100 consecutive patients referred to a thyroid clinic. Clin Endocrinol (Oxf) (1973) 1.45
Patients' accounts of calling the doctor out of hours: qualitative study in one general practice. BMJ (1996) 1.45
Asymptomatic thyrotropin-secreting pituitary microadenoma. Intern Med J (2001) 1.45
Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr (2000) 1.42
Nocturnal asthma: features of attacks, sleep and breathing patterns. Am Rev Respir Dis (1982) 1.41
[Role of homocysteine in the acute phase of stroke]. Neurologia (2004) 1.40
Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke (2001) 1.40
["Stroke code". Shortening the delay in reperfusion treatment of acute ischemic stroke]. Med Clin (Barc) (1999) 1.39
[Neurological manifestations of Fabry disease]. Rev Neurol (2006) 1.39
Ultrastructural localization of dystrophin in human muscle by using gold immunolabelling. Proc R Soc Lond B Biol Sci (1990) 1.38
Meningioma: a late complication of head injury. Med J Aust (1969) 1.38
Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet (1998) 1.36
Roots as a site of hydrogen sulfide uptake in the hydrocarbon seep vestimentiferan Lamellibrachia sp. J Exp Biol (1999) 1.35
Heterosexual outbreak of infectious syphilis: epidemiological and ethnographic analysis and implications for control. Sex Transm Infect (2002) 1.31
Prevention of spinal cord injuries in Australia. Paraplegia (1987) 1.30
CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. HIV Med (2007) 1.30
Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo. Oncogene (2011) 1.29
Public injecting among a cohort of injecting drug users in Vancouver, Canada. J Epidemiol Community Health (2008) 1.29
The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry (2006) 1.28
Multiplex PCR for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Genitourinary specimens. J Clin Microbiol (1995) 1.28
The legume-Rhizobium symbiosis: a cell surface interaction. J Cell Sci Suppl (1985) 1.27
Changing physician prescribing patterns: evaluation of an educational strategy for acute diarrhea in Mexico City. Med Care (1994) 1.27
Nicotine chewing gum in general practice: effect of follow up appointments. Br Med J (Clin Res Ed) (1985) 1.26
Drastic elevations in mortality among female injection drug users in a Canadian setting. AIDS Care (2006) 1.25
Determination of diffusion coefficients of haemocyanin at low concentration by intensity fluctuation spectroscopy of scattered laser light. Nature (1970) 1.24
Effects of shaker-1 mutations on myosin-VIIa protein and mRNA expression. Cell Motil Cytoskeleton (1997) 1.24
Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology (2009) 1.24
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations. HIV Med (2010) 1.23
Differential tissue distribution, developmental programming, estrogen regulation and promoter characteristics of cyp19 genes in teleost fish. J Steroid Biochem Mol Biol (2001) 1.23
Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology (1999) 1.23
Molecular mapping of the mouse ob mutation. Genomics (1991) 1.21
Factors associated with sex trade involvement among male participants in a prospective study of injection drug users. Sex Transm Infect (2004) 1.21
The Causative Classification of Stroke system: an international reliability and optimization study. Neurology (2010) 1.19
Mutation analysis of the mouse myosin VIIA deafness gene. Genes Funct (1997) 1.19
Vasoactive intestinal peptide: a neurotransmitter for relaxation of the rabbit internal anal sphincter. Gastroenterology (1985) 1.18
Sensory system involvement in infantile spinal muscular atrophy. J Neurol Sci (1975) 1.17
Chylous ascites: a late complication of intra-abdominal Mycobacterium avium complex immune reconstitution syndrome in HIV-infected patients. Int J STD AIDS (2009) 1.17
Mortality following spinal cord injury. Spinal Cord (1998) 1.16
Recurrent Helicobacter cinaedi cellulitis and bacteraemia in a patient with HIV Infection. Int J STD AIDS (1997) 1.16
Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care (1995) 1.16
Genetic vulnerability down on the farm. Science (1981) 1.15